These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 17305652

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of peroxisome proliferator-activated receptor gamma agonist treatment on subclinical atherosclerosis in patients with insulin-requiring type 2 diabetes.
    Hodis HN, Mack WJ, Zheng L, Li Y, Torres M, Sevilla D, Stewart Y, Hollen B, Garcia K, Alaupovic P, Buchanan TA.
    Diabetes Care; 2006 Jul; 29(7):1545-53. PubMed ID: 16801577
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Glucose turnover and intima media thickness of internal carotid artery in type 2 diabetes offspring.
    Anderwald C, Pfeiler G, Nowotny P, Anderwald-Stadler M, Krebs M, Bischof MG, Kozakova M, Luger A, Pacini G, Roden M, Waldhäusl W.
    Eur J Clin Invest; 2008 Apr; 38(4):227-37. PubMed ID: 18339003
    [Abstract] [Full Text] [Related]

  • 5. Effects of rosiglitazone on body fat distribution and insulin sensitivity in Korean type 2 diabetes mellitus patients.
    Hwang YC, Lee EY, Lee WJ, Cha BS, Yoon KH, Park KS, Lee MK.
    Metabolism; 2008 Apr; 57(4):479-87. PubMed ID: 18328348
    [Abstract] [Full Text] [Related]

  • 6. Retinopathy in type 2 diabetes mellitus is associated with increased intima-media thickness and endothelial dysfunction.
    Malecki MT, Osmenda G, Walus-Miarka M, Skupien J, Cyganek K, Mirkiewicz-Sieradzka B, damek-Guzik TA, Guzik TJ, Sieradzki J.
    Eur J Clin Invest; 2008 Dec; 38(12):925-30. PubMed ID: 19021717
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure.
    Dargie HJ, Hildebrandt PR, Riegger GA, McMurray JJ, McMorn SO, Roberts JN, Zambanini A, Wilding JP.
    J Am Coll Cardiol; 2007 Apr 24; 49(16):1696-704. PubMed ID: 17448371
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inflammatory markers, insulin resistance and carotid intima-media thickness in North-Indian type 2 diabetic subjects.
    Ahmad J, Ahmned F, Siddiqui MA, Khan AR, Katyal P, Hameed B, Ahmad I.
    J Assoc Physicians India; 2007 Oct 24; 55():693-9. PubMed ID: 18173021
    [Abstract] [Full Text] [Related]

  • 11. The level of 2-h post-challenge glucose is an independent risk factor of carotid intima-media thickness progression in Korean type 2 diabetic patients.
    Kim HJ, Ahn CW, Kang ES, Myoung SM, Cha BS, Won YJ, Lim SK, Kim KR, Huh KB, Lee HC.
    J Diabetes Complications; 2007 Oct 24; 21(1):7-12. PubMed ID: 17189868
    [Abstract] [Full Text] [Related]

  • 12. Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study.
    Langenfeld MR, Forst T, Hohberg C, Kann P, Lübben G, Konrad T, Füllert SD, Sachara C, Pfützner A.
    Circulation; 2005 May 17; 111(19):2525-31. PubMed ID: 15883215
    [Abstract] [Full Text] [Related]

  • 13. Changing associations between progressive cardiovascular autonomic neuropathy and carotid atherosclerosis with increasing duration of type 2 diabetes mellitus.
    Gottsäter A, Szelag B, Berglund G, Wroblewski M, Sundkvist G.
    J Diabetes Complications; 2005 May 17; 19(4):212-7. PubMed ID: 15993355
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intima-media thickness of the carotid arteries in subjects with hyperinsulinaemia (insulin resistance).
    Hidvégi T, Szatmári F, Hetyési K, Bíró L, Jermendy G.
    Diabetes Nutr Metab; 2003 Jun 17; 16(3):139-44. PubMed ID: 14635730
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inverse correlation between activated protein C generation and carotid atherosclerosis in Type 2 diabetic patients.
    Matsumoto K, Yano Y, Gabazza EC, Araki R, Bruno NE, Suematsu M, Akatsuka H, Katsuki A, Taguchi O, Adachi Y, Sumida Y.
    Diabet Med; 2007 Dec 17; 24(12):1322-8. PubMed ID: 17971179
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus.
    Sidhu JS, Kaposzta Z, Markus HS, Kaski JC.
    Arterioscler Thromb Vasc Biol; 2004 May 17; 24(5):930-4. PubMed ID: 15001452
    [Abstract] [Full Text] [Related]

  • 20. The association of smoking and subclinical atherosclerosis in Type 2 diabetes: modification by duration of diabetes.
    Karim R, Buchanan TA, Hodis HN, Li Y, Mack WJ.
    Diabet Med; 2005 Jan 17; 22(1):81-7. PubMed ID: 15606696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.